ArticleNature communications2018

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.

Kyota Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.